Royal Bank of Canada’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Hold
0
7329
2025
Q3
Hold
0
7270
2025
Q2
Hold
0
7135
2025
Q1
Sell
-5
Closed -$2.78K 6970
2024
Q4
$4K Buy
+5
New +$6.55K ﹤0.01% 6575
2024
Q3
Hold
0
7071
2024
Q2
Hold
0
7233
2024
Q1
Hold
0
7225
2023
Q4
Hold
0
6925
2023
Q3
Hold
0
6888
2023
Q2
Hold
0
6787
2023
Q1
Hold
0
6688
2022
Q4
Hold
0
6787
2022
Q3
Hold
0
6728
2022
Q2
Hold
0
6719
2022
Q1
Hold
0
7107
2021
Q4
Hold
0
7334
2021
Q3
Sell
-2
Closed -$259K 7056
2021
Q2
$349K Hold
2
﹤0.01% 4587
2021
Q1
$453K Buy
+2
New +$439K ﹤0.01% 4275
2020
Q4
Hold
0
6066

Other funds holding GNPX

Royal Bank of Canada's GNPX Position: Q4 2025 in Review

Royal Bank of Canada held its Genprex (GNPX) position steady in Q4 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7329.

Royal Bank of Canada first reported a position in GNPX in Q1 2021 and has held it in 3 quarters since. The position peaked at $453K in Q1 2021. 9 funds tracked by Wall St. Rank hold GNPX as of Q4 2025.

  • Royal Bank of Canada held 0 shares of Genprex worth $0 as of Q4 2025.
  • Royal Bank of Canada left its Genprex share count unchanged in Q4 2025.
  • Genprex made up ﹤0.01% of Royal Bank of Canada's portfolio in Q4 2025, its #7329 holding.
  • Royal Bank of Canada first reported a position in Genprex in Q1 2021 and has held it in 3 quarters since.
  • Royal Bank of Canada's Genprex position peaked at $453K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Genprex as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.